🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Akila Viswanathan

Harvard University

ORCID: 0000-0002-0007-2296

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Dana-Farber Cancer Institute, Sidney Kimmel Comprehensive Cancer Center

Physics and AstronomyMedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Single Radiotherapy Fraction with Local Anti-CD40 Therapy Generates Effective Abscopal Responses in Mouse Models of Cervical Cancer”.

Single Radiotherapy Fraction with Local Anti-CD40 Therapy Generates Effective Abscopal Responses in Mouse Models of Cervical Cancer

Cancers(2020)10.3390/cancers12041026
N/A
0DataRank · unranked
19 citations

Sayeda Yasmin‐Karim, Romy Mueller, Akila Viswanathan, Wilfred Ngwa, J. Wood

Fully automated multiorgan segmentation of female pelvic magnetic resonance images with coarse‐to‐fine convolutional neural network

Medical Physics(2021)10.1002/mp.15268
N/A
0DataRank · unranked
27 citations

Akila Viswanathan, Ehud J. Schmidt, Marc Morcos, Junghoon Lee, Fatemeh Zabihollahy

Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment

Nanomaterials(2023)10.3390/nano13101656
N/A
0DataRank · unranked
43 citations

Michèle Moreau, Robert Ivkov, Akila Viswanathan, Wilfred Ngwa, Shahinur Acter

Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy

Radiation Oncology(2024)10.1186/s13014-024-02499-2
N/A
0DataRank · unranked
4 citations

Bruce L. Daniel, Michael Roumeliotis, Junghoon Lee, William T. Hrinivich, Thomas Benkert +5 more